Cargando…

Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma

BACKGROUND: Aging is a process that biological changes accumulate with time and lead to increasing susceptibility to diseases like cancer. This study is aimed at establishing an aging-related prognostic signature in colon adenocarcinoma (COAD). METHODS: The transcriptome data and clinical variables...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Lian, Yang, Yang, Cui, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592697/
https://www.ncbi.nlm.nih.gov/pubmed/34790819
http://dx.doi.org/10.1155/2021/4682589
_version_ 1784599520763445248
author Zheng, Lian
Yang, Yang
Cui, Xiaorong
author_facet Zheng, Lian
Yang, Yang
Cui, Xiaorong
author_sort Zheng, Lian
collection PubMed
description BACKGROUND: Aging is a process that biological changes accumulate with time and lead to increasing susceptibility to diseases like cancer. This study is aimed at establishing an aging-related prognostic signature in colon adenocarcinoma (COAD). METHODS: The transcriptome data and clinical variables of COAD patients were downloaded from TCGA database. The genes in GOBP_AGING gene set was used for prognostic evaluation by the univariate and multivariate Cox regression analyses. The model was presented by a nomogram and assessed by the Kaplan-Meier curves and calibration curves. The drug response and gene mutation were also performed to implicate the clinical significance. The GO and KEGG analyses were employed to unravel the potential functional mechanism. RESULTS: The Gene Set Enrichment Analysis result indicates that GOBP_AGING pathway is significantly enriched in COAD samples. Four aging-related genes are finally used to construct the aging-related prognostic signature: FOXM1, PTH1R, KL, and CGAS. The COAD patients with high risk score have much shorter overall survival in both train cohort and test cohort. The nomogram is then assembled to predict 1-year, 3-year, and 5-year survival. Patients with high risk score have elevated infiltrating B cell naïve and attenuated cisplatin sensitivity. The mutation landscape shows that the TTN, FAT4, ZFHX4, APC, and OBSCN gene mutation are different between high risk score patients and low risk score patients. The differentially expressed genes between patients with high score and low score are enriched in B cell receptor signaling pathway. CONCLUSION: We constructed an aging-related signature in COAD patients, which can predict oncological outcome and optimize therapeutic strategy.
format Online
Article
Text
id pubmed-8592697
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-85926972021-11-16 Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma Zheng, Lian Yang, Yang Cui, Xiaorong Biomed Res Int Research Article BACKGROUND: Aging is a process that biological changes accumulate with time and lead to increasing susceptibility to diseases like cancer. This study is aimed at establishing an aging-related prognostic signature in colon adenocarcinoma (COAD). METHODS: The transcriptome data and clinical variables of COAD patients were downloaded from TCGA database. The genes in GOBP_AGING gene set was used for prognostic evaluation by the univariate and multivariate Cox regression analyses. The model was presented by a nomogram and assessed by the Kaplan-Meier curves and calibration curves. The drug response and gene mutation were also performed to implicate the clinical significance. The GO and KEGG analyses were employed to unravel the potential functional mechanism. RESULTS: The Gene Set Enrichment Analysis result indicates that GOBP_AGING pathway is significantly enriched in COAD samples. Four aging-related genes are finally used to construct the aging-related prognostic signature: FOXM1, PTH1R, KL, and CGAS. The COAD patients with high risk score have much shorter overall survival in both train cohort and test cohort. The nomogram is then assembled to predict 1-year, 3-year, and 5-year survival. Patients with high risk score have elevated infiltrating B cell naïve and attenuated cisplatin sensitivity. The mutation landscape shows that the TTN, FAT4, ZFHX4, APC, and OBSCN gene mutation are different between high risk score patients and low risk score patients. The differentially expressed genes between patients with high score and low score are enriched in B cell receptor signaling pathway. CONCLUSION: We constructed an aging-related signature in COAD patients, which can predict oncological outcome and optimize therapeutic strategy. Hindawi 2021-11-08 /pmc/articles/PMC8592697/ /pubmed/34790819 http://dx.doi.org/10.1155/2021/4682589 Text en Copyright © 2021 Lian Zheng et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zheng, Lian
Yang, Yang
Cui, Xiaorong
Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
title Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
title_full Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
title_fullStr Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
title_full_unstemmed Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
title_short Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
title_sort establishing and validating an aging-related prognostic four-gene signature in colon adenocarcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592697/
https://www.ncbi.nlm.nih.gov/pubmed/34790819
http://dx.doi.org/10.1155/2021/4682589
work_keys_str_mv AT zhenglian establishingandvalidatinganagingrelatedprognosticfourgenesignatureincolonadenocarcinoma
AT yangyang establishingandvalidatinganagingrelatedprognosticfourgenesignatureincolonadenocarcinoma
AT cuixiaorong establishingandvalidatinganagingrelatedprognosticfourgenesignatureincolonadenocarcinoma